New Delhi, Sep 28 (PTI) Sun Pharmaceutical Industries Ltd on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million (over Rs 75 crore).

The company has signed a binding letter of intent to acquire the balance 25 per cent outstanding shares of Sun Pharma de Mexico, SA de CV, a subsidiary where it currently holds 75 per cent shares, Sun Pharmaceutical Industries said in a regulatory filing.

Also Read | Punjab Farmers Begin Three-Day ‘Rail Roko’ Protest Demanding Financial Package for Flood-Caused Losses and Debt Waiver (Watch Video).

The balance of 25 per cent is held by local partner Indi Pharma S.A.P.I. de CV, it added.

The cost of acquisition is MXN 161.85 million, it added.

Also Read | Lalbaugcha Raja 2023 Visarjan Route: Details of Immersion Path Revealed; Mumbai Traffic Police Issue Traffic Advisory Ahead of Anant Chaturdashi.

"The acquisition enables Sun Pharma to acquire the balance 25 per cent stake held by the local partner," the company said, adding it would be done through a wholly-owned subsidiary Sun Pharma (Netherlands) B.V.

The acquisition is likely to be completed by October 31, 2023, and after that, Sun Pharma de Mexico SA de CV will become a wholly-owned subsidiary of the company, it said.

Sun Pharma de Mexico is engaged in the marketing and distribution of pharmaceutical products in Mexico.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)